Indian Generics Maker Warned for Repeat CGMP Violations

Drug Industry Daily
A A
Indian drugmaker Jubilant Generics drew an FDA warning letter over repeat quality violations and inadequate complaint investigations at a facility in the northern state of Uttarakhand.

To View This Article:

Login

Subscribe To Drug Industry Daily